Oseltamivir-13C2,d3 Phosphate
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Oseltamivir-13C2,d3 Phosphate Product Information
Oseltamivir-13C2,d3 Phosphate is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-99921.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Oseltamivir-13C2,d3 Phosphate
CAT No.
CS-T-99921
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C1413C2H28D3N2O8P
Molecular Weight
415.4
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Oseltamivir-13C2,d3 Phosphate is supplied with detailed characterization data compliant with regulatory guideline. Oseltamivir-13C2,d3 Phosphate can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
Labelled Oseltamivir (O701000). Orally active inhibitor of influenza virus neuraminidase; converted in vivo to the active acid metabolite. An antiviral drug. It is a COVID19-related research product.
Synonyms
Oseltamivir-13C2,d3 Phosphate
Application Notes
Labelled Oseltamivir (O701000). Orally active inhibitor of influenza virus neuraminidase; converted in vivo to the active acid metabolite. An antiviral drug. It is a COVID19-related research product.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.